The impact of glycosyl-phosphatidyl-inositol anchored MICA alleles on novel NKG2D-based therapies

Frontiers in Immunology

Volumn 6, Issue APR, 2015, Pages

  Valés Gómez, Mar ^a  

^a CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

Author keywords

Exosomes; GPI anchored proteins; HCMV; Immune evasion; MICA B; NKG2D; NKG2D ligands; ULBP

Indexed keywords

GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I RELATED CHAIN A; MEMBRANE PROTEIN; METALLOPROTEINASE; NATURAL KILLER CELL RECEPTOR NKG2D; UNCLASSIFIED DRUG;

ALLELE; ARTICLE; CD4 T LYMPHOCYTE; DOWN REGULATION; HUMAN; IMMUNE EVASION; IMMUNOREGULATION; MUTATION; PROTEIN EXPRESSION;

EID: 84934268042     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2015.00193     Document Type: Article

References (20)

1. Raulet DH, Gasser S, Gowen BG, Deng W, Jung H. Regulation of ligands for the NKG2D activating receptor. Annu Rev Immunol (2013) 31:413-41. doi: 10.1146/annurev-immunol-032712-095951
2. Nausch N, Cerwenka A. NKG2D ligands in tumor immunity. Oncogene (2008) 27:5944-58. doi:10.1038/onc.2008.272
3. Chitadze G, Bhat J, Lettau M, Janssen O, Kabelitz D. Generation of soluble NKG2D ligands: proteolytic cleavage, exosome secretion and functional implications. Scand J Immunol (2013) 78:120-9. doi:10.1111/sji.12072
4. Vyas M, Koehl U, Hallek M, Von Strandmann EP. Natural ligands and antibody-based fusion proteins: harnessing the immune system against cancer. Trends Mol Med (2014) 20:72-82. doi:10.1016/j.molmed.2013.10.006
5. Fernandez-Messina L, Reyburn HT, Vales-Gomez M. Human NKG2D-ligands: cell biology strategies to ensure immune recognition. Front Immunol (2012) 3:299. doi:10.3389/fimmu.2012.00299
6. Ashiru O, Lopez-Cobo S, Fernandez-Messina L, Pontes-Quero S, Pandolfi R, Reyburn HT, et al. A GPI anchor explains the unique biological features of the common NKG2D-ligand allele MICA*008. Biochem J (2013) 454:295-302. doi:10.1042/BJ20130194
7. Seidel E, Le VT, Bar-On Y, Tsukerman P, Enk J, Yamin R, et al. Dynamic co-evolution of host and pathogen: HCMV downregulates the prevalent allele MICA *008 to escape elimination by NK cells. Cell Rep (2015) 10(6):968-82. doi:10.1016/j.celrep.2015.01.029
8. Mellergaard M, Skovbakke SL, Schneider CL, Lauridsen F, Andresen L, Jensen H, et al. N-glycosylation of asparagine 8 regulates surface expression of major histocompatibility complex class I chain-related protein A (MICA) alleles dependent on threonine 24. J Biol Chem (2014) 289:20078-91. doi:10.1074/jbc. M114.573238
9. Ashiru O, Boutet P, Fernandez-Messina L, Aguera-Gonzalez S, Skepper JN, Vales-Gomez M, et al. Natural killer cell cytotoxicity is suppressed by exposure to the human NKG2D ligand MICA*008 that is shed by tumor cells in exosomes. Cancer Res (2010) 70:481-9. doi:10.1158/0008-5472.CAN-09-1688
10. Tonnerre P, Gerard N, Chatelais M, Poli C, Allard S, Cury S, et al. MICA variant promotes allosensitization after kidney transplantation. J Am Soc Nephrol (2013) 24:954-66. doi:10.1681/ASN.2012080814
11. Fernandez-Messina L, Ashiru O, Boutet P, Aguera-Gonzalez S, Skepper JN, Reyburn HT, et al. Differential mechanisms of shedding of the glycosylphosphatidylinositol (GPI)-anchored NKG2D ligands. J Biol Chem (2010) 285:8543-51. doi:10.1074/jbc. M109.045906
12. Sutherland CL, Chalupny NJ, Cosman D. The UL16-binding proteins, a novel family of MHC class I-related ligands for NKG2D, activate natural killer cell functions. Immunol Rev (2001) 181:185-92. doi:10.1034/j.1600-065X.2001.1810115.x
13. Fielding CA, Aicheler R, Stanton RJ, Wang EC, Han S, Seirafian S, et al. Two novel human cytomegalovirus NK cell evasion functions target MICA for lysosomal degradation. PLoS Pathog (2014) 10:e1004058. doi:10.1371/journal.ppat.1004058
14. Jasinski-Bergner S, Mandelboim O, Seliger B. The role of microRNAs in the control of innate immune response in cancer. J Natl Cancer Inst (2014) 106(10):1-13. doi:10.1093/jnci/dju257
15. Chalupny NJ, Rein-Weston A, Dosch S, Cosman D. Down-regulation of the NKG2D ligand MICA by the human cytomegalovirus glycoprotein UL142. Biochem Biophys Res Commun (2006) 346:175-81. doi:10.1016/j.bbrc.2006.05.092
16. Ashiru O, Bennett NJ, Boyle LH, Thomas M, Trowsdale J, Wills MR. NKG2D ligand MICA is retained in the cis-Golgi apparatus by human cytomegalovirus protein UL142. J Virol (2009) 83:12345-54. doi:10.1128/JVI.01175-09
17. Zou Y, Bresnahan W, Taylor RT, Stastny P. Effect of human cytomegalovirus on expression of MHC class I-related chains A. J Immunol (2005) 174:3098-104. doi:10.4049/jimmunol.174.5.3098
18. Stern-Ginossar N, Elefant N, Zimmermann A, Wolf DG, Saleh N, Biton M, et al. Host immune system gene targeting by a viral miRNA. Science (2007) 317:376-81. doi:10.1126/science.1140956
19. Kinoshita T, Maeda Y, Fujita M. Transport of glycosylphosphatidylinositol-anchored proteins from the endoplasmic reticulum. Biochim Biophys Acta (2013) 1833:2473-8. doi:10.1016/j.bbamcr.2013.01.027
20. Kinoshita T. Biosynthesis and deficiencies of glycosylphosphatidylinositol. Proc Jpn Acad Ser B Phys Biol Sci (2014) 90:130-43. doi:10.2183/pjab.90.130